Sanofi launches new long-acting insulin drug in India

Soliqua is indicated as treatment to improve glycemic control as an adjunct to diet and exercise, in adults with obesity and type 2 diabetes who are insufficiently controlled on oral or injectable therapies.It comes in once daily dosing of pre-filled pens in fixed-ratio combination of 10-40 and 30-60 of insulin glargine and lixisenatide.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dPNXHbi
via IFTTT